News
Pershing Square Capital Management's billionaire chief has sold most of his fund's stake in Chipotle over seven years, and is ...
1d
MarketBeat on MSNChipotle: Too Spicy for Smart Money to Resist After Stock SplitJust weeks after its landmark 50-for-1 stock split made shares more affordable for employees and a broader base of investors, ...
HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...
22h
Zacks Investment Research on MSNOnto Innovation (ONTO) Falls More Steeply Than Broader Market: What Investors Need to KnowIn the latest close session, Onto Innovation (ONTO) was down 1.08% at $101.76. This change lagged the S&P 500's 0.33% loss on the day. Meanwhile, the Dow experienced a drop of 0.63%, and the ...
Federated Hermes shines with an asset-light model, strong AUM growth, 3% yield, private market moves, and value-driven ...
The dual circulation jointly built by Shanghai and Hong Kong as the country's two currency hubs is especially important in ...
Use of tools like Claude AI to analyse portfolios and get buy and sell stock recommendations pose a new challenge for advisors and investment managers.
Reliance Infrastructure endures short-term volatility amid SBI’s Reliance Communications probe, yet solid power-sector ...
Flipkart announced a $50 million employee stock buyback for over 7500 employees ahead of Diwali. CEO Kalyan Krishnamurthy praised the team's achievements and future goals.
Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...
The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results